Whats new
Whats new.
CLSA - Big empty; Merck’s weak TIGIT Ph2 update in contrast to LAG-3’s promising outlook; Mtn Buy, A$0.95 Tgt (Analyst: Andrew Paine)
December 11th 2023
For a copy of this research report please contact your CLSA advisor
Whats new
December 11th 2023
For a copy of this research report please contact your CLSA advisor